EMA 'Completely Reworks' Parts Of Gene Therapy Products Guideline
Executive Summary
The European Medicines Agency has revised several sections of its 2001 guidance on the development and evaluation of gene therapy medicinal products based on stakeholder feedback and to address issues in light of the experience gained with these products.